Fas-Independent Fashion Cells in a MHC Antigen-and Immunoreceptor Efficiently Lyse Target T Cells Engrafted with a Recombinant + CD 4 Hinrich
暂无分享,去创建一个
[1] V. Diehl,et al. An entirely humanized CD3 ζ‐chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen–positive tumor cells , 2000, International journal of cancer.
[2] R. Korngold,et al. Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. , 2000, Blood.
[3] J. Trapani,et al. Redirected Perforin-Dependent Lysis of Colon Carcinoma by Ex Vivo Genetically Engineered CTL1 , 2000, The Journal of Immunology.
[4] S. Fujita,et al. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.
[5] V. Diehl,et al. T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition. , 2000, Gene therapy.
[6] A. Rothman,et al. Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones , 1999, Journal of Virology.
[7] V. Diehl,et al. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA , 1998, Gene Therapy.
[8] A. Hasegawa,et al. Simplex Virus-Infected Cells CTL Directed Against Herpes + Human CD 4 Fas-Independent Cytotoxicity Mediated , 1999 .
[9] T. Ley,et al. How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.
[10] M. Weijtens,et al. A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes , 1998, Gene Therapy.
[11] U. Reinhold,et al. Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? , 1998, Immunology today.
[12] T. Ley,et al. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. , 1997, The Journal of clinical investigation.
[13] C. von Kalle,et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. , 1996, Blood.
[14] S. Rosenberg,et al. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. , 1995, Cancer research.
[15] R. Ueda,et al. Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] B. Groner,et al. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[18] V. Diehl,et al. CD30‐specific AB1‐AB2‐AB3 internal image antibody network: Potential use as anti‐idiotype vaccine against Hodgkin's lymphoma , 1993, International journal of cancer.
[19] Z. Eshhar,et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] W. Dippold,et al. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing. , 1993, The Year in immunology.
[21] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[22] J. Kirkwood,et al. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. , 1992, Journal of immunological methods.
[23] V. Diehl,et al. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice. , 1990, Cancer research.